SEJ-83446-34071
4 vaccinations
2 coded responses
52 check-ins
2 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 303 / GA
- Registered
- 2021-03-16
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-16
Registered in v-safe
-
2021-03-16
Dose 1 — Pfizer-BioNTech
- 2021-03-16
- 2021-03-17
- 2021-03-18
- 2021-03-19
- 2021-03-20
- 2021-03-21
- 2021-03-23
- 2021-03-30
-
2021-04-06
Dose 2 — Pfizer-BioNTech
- 2021-04-06
-
2021-04-07
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Muscle or body aches, Fatigue or tiredness, Nausea, Vomiting, Abdominal pain · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-04-08
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Chills, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to do your normal daily activitiesAdult check-in
-
2021-04-09
Survey response — days 1–6 daily, dose 2MedDRA: Lymphadenopathy — Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tirednessFree text: Swollen lymph nodes (especially under injection site arm)MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-10
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-04-11
- 2021-04-12
- 2021-04-13
- 2021-04-20
- 2021-04-27
- 2021-05-04
- 2021-05-11
- 2021-05-18
- 2021-07-06
- 2021-10-05
-
2021-11-21
Dose 3 — Pfizer-BioNTech
- 2021-11-21
-
2021-11-22
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea, Vomiting · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2021-11-23
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-11-24
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-11-25
- 2021-11-26
- 2021-11-27
- 2021-11-28
- 2021-12-05
- 2021-12-12
- 2021-12-19
- 2021-12-26
- 2022-01-02
- 2022-02-20
- 2022-05-22
-
2022-10-02
Dose 4 — Pfizer-BioNTech
-
2022-10-03
Survey response — days 1–6 daily, dose 4MedDRA: Insomnia — Feeling: Fair · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tirednessFree text: Trouble sleepingMedDRA releases: 2024-11 · check-in free text available
-
2022-10-04
Health check-in — days 1–6 daily, dose 4Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2022-10-05
- 2022-10-06
- 2022-10-07
- 2022-10-08
- 2022-10-09
- 2022-10-16
- 2022-10-23
- 2022-10-30
- 2022-11-06
- 2022-11-13
- 2023-01-01
- 2023-04-02
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-16 | Pfizer-BioNTech | |
| 2 | 2021-04-06 | Pfizer-BioNTech | |
| 3 | 2021-11-21 | Pfizer-BioNTech | No |
| 4 | 2022-10-02 | Pfizer-BioNTech | No |
Free text
Release 7 — days 1–6 daily, dose 2
Systemic reaction (other): Swollen lymph nodes (especially under injection site arm)
Release 12 — days 1–6 daily, dose 4
Systemic reaction (other): Trouble sleeping
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Insomnia | · | · | ✓ |
| SRO | Lymphadenopathy | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release